+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA eClinical solutions Market Size, Share & Industry Trends Analysis Report By Delivery Mode, By Product, By Clinical Trials Phase (Phase III, Phase II, Phase IV and Phase I), By End User, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 106 Pages
  • August 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5658844
The Latin America, Middle East and Africa eClinical solutions Market is expected to witness market growth of 17.1% CAGR during the forecast period (2022-2028).

The volume of data created is tremendous as a result of the Internet of Things (IoT) and the digitization of healthcare, and it contains data that can be easily retrieved through electronic data mining, which was previously unattainable with paper records. It is anticipated that eClinical solutions will significantly affect this field. The widespread use of eClinical solutions is mostly owing to the requirement to maintain transparency, remove redundancy, and combat data fraud associated with medical research.

Considering the complexity of data management procedures in diabetic clinical trials and the extensive use of information technology in research, the adoption of clinical data management systems in these trials seems necessary. During clinical trials, a clinical data management system is a piece of software that facilitates data management and helps to reduce errors that can happen when data is managed manually.

Clinical trials that use software solutions experience significant market expansion. Additionally, a growing tendency toward outsourcing clinical trial services to CROs (Contract Research Organizations) and an increase in the number of life sciences companies and CROs are expected to increase. Research efforts in Asian nations are rising in order to create affordable modules or solutions.

The UAE offers a robust healthcare infrastructure as one of the Middle East's most economically advanced and diverse markets. The government of the UAE has made building a top-notch healthcare infrastructure a primary priority, and as a result, the industry has developed and grown considerably over the past few years. The government of UAE has moved swiftly to implement preventative health measures. The UAE's healthcare industry has grown to accommodate both the country's population's changing needs and its ambition to establish itself as a regional center for medical tourism.

The Brazil market dominated the LAMEA eClinical Solutions Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $335.1 Million by 2028. The Argentina market is poised to grow at a CAGR of 17.7% during (2022 - 2028). Additionally, The UAE market is expected to witness a CAGR of 16.7% during (2022 - 2028).

Based on Delivery Mode, the market is segmented into Web-based (on-demand) Model, Licensed enterprise (On-premise) Model and Cloud-based (SaaS) Model. Based on Product, the market is segmented into CDMS/EDC Solutions, CTMS Solutions, Analytics & Reporting Platforms, Safety Solutions, Integration Platforms, RTMS Solutions, eCOA Solutions and Others. Based on Clinical Trials Phase, the market is segmented into Phase III, Phase II, Phase IV and Phase I. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutions, Hospitals, Contract Research Organizations, Medical Device Manufacturers and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Anju Software, Inc., eClinical Solutions LLC, Castor EDC, Signant Health, Dassault Systemes SE, Parexel International Corporation (Phoenix Parentco, Inc.), Clario, BSI Life Sciences (Business Systems Integration AG) and MedNet Solutions

Scope of the Study

Market Segments Covered in the Report:

By Delivery Mode
  • Web-based (on-demand) Model
  • Licensed enterprise (on-premise) Model
  • Cloud-based (saas) Model
By Product
  • CDMS/EDC Solutions
  • CTMS Solutions
  • Analytics & Reporting Platforms
  • Safety Solutions
  • Integration Platforms
  • RTMS Solutions
  • eCOA Solutions
  • Others
By Clinical Trials Phase
  • Phase III
  • Phase II
  • Phase IV
  • Phase I
By End User
  • Pharmaceutical & Biopharmaceutical Companies
  • Academic Research Institutions
  • Hospitals
  • Contract Research Organizations
  • Medical Device Manufacturers
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Oracle Corporation
  • Anju Software, Inc.
  • eClinical Solutions LLC
  • Castor EDC
  • Signant Health
  • Dassault Systemes SE
  • Parexel International Corporation (Phoenix Parentco, Inc.)
  • Clario
  • BSI Life Sciences (Business Systems Integration AG)
  • MedNet Solutions

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA eClinical Solutions Market, by Delivery Mode
1.4.2 LAMEA eClinical Solutions Market, by Product
1.4.3 LAMEA eClinical Solutions Market, by Clinical Trials Phase
1.4.4 LAMEA eClinical Solutions Market, by End User
1.4.5 LAMEA eClinical Solutions Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in eClinical solutions Market
Chapter 4. LAMEA eClinical Solutions Market by Delivery Mode
4.1 LAMEA Web-based (on-demand) Model Market by Country
4.2 LAMEA Licensed enterprise (on-premise) Model Market by Country
4.3 LAMEA Cloud-based (saas) Model Market by Country
Chapter 5. LAMEA eClinical Solutions Market by Product
5.1 LAMEA CDMS/EDC Solutions Market by Country
5.2 LAMEA CTMS Solutions Market by Country
5.3 LAMEA Analytics & Reporting Platforms Market by Country
5.4 LAMEA Safety Solutions Market by Country
5.5 LAMEA Integration Platforms Market by Country
5.6 LAMEA RTMS Solutions Market by Country
5.7 LAMEA eCOA Solutions Market by Country
5.8 LAMEA Others Market by Country
Chapter 6. LAMEA eClinical Solutions Market by Clinical Trials Phase
6.1 LAMEA Phase III Market by Country
6.2 LAMEA Phase II Market by Country
6.3 LAMEA Phase IV Market by Country
6.4 LAMEA Phase I Market by Country
Chapter 7. LAMEA eClinical Solutions Market by End User
7.1 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country
7.2 LAMEA Academic Research Institutions Market by Country
7.3 LAMEA Hospitals Market by Country
7.4 LAMEA Contract Research Organizations Market by Country
7.5 LAMEA Medical Device Manufacturers Market by Country
7.6 LAMEA Others Market by Country
Chapter 8. LAMEA eClinical Solutions Market by Country
8.1 Brazil eClinical Solutions Market
8.1.1 Brazil eClinical Solutions Market by Delivery Mode
8.1.2 Brazil eClinical Solutions Market by Product
8.1.3 Brazil eClinical Solutions Market by Clinical Trials Phase
8.1.4 Brazil eClinical Solutions Market by End User
8.2 Argentina eClinical Solutions Market
8.2.1 Argentina eClinical Solutions Market by Delivery Mode
8.2.2 Argentina eClinical Solutions Market by Product
8.2.3 Argentina eClinical Solutions Market by Clinical Trials Phase
8.2.4 Argentina eClinical Solutions Market by End User
8.3 UAE eClinical Solutions Market
8.3.1 UAE eClinical Solutions Market by Delivery Mode
8.3.2 UAE eClinical Solutions Market by Product
8.3.3 UAE eClinical Solutions Market by Clinical Trials Phase
8.3.4 UAE eClinical Solutions Market by End User
8.4 Saudi Arabia eClinical Solutions Market
8.4.1 Saudi Arabia eClinical Solutions Market by Delivery Mode
8.4.2 Saudi Arabia eClinical Solutions Market by Product
8.4.3 Saudi Arabia eClinical Solutions Market by Clinical Trials Phase
8.4.4 Saudi Arabia eClinical Solutions Market by End User
8.5 South Africa eClinical Solutions Market
8.5.1 South Africa eClinical Solutions Market by Delivery Mode
8.5.2 South Africa eClinical Solutions Market by Product
8.5.3 South Africa eClinical Solutions Market by Clinical Trials Phase
8.5.4 South Africa eClinical Solutions Market by End User
8.6 Nigeria eClinical Solutions Market
8.6.1 Nigeria eClinical Solutions Market by Delivery Mode
8.6.2 Nigeria eClinical Solutions Market by Product
8.6.3 Nigeria eClinical Solutions Market by Clinical Trials Phase
8.6.4 Nigeria eClinical Solutions Market by End User
8.7 Rest of LAMEA eClinical Solutions Market
8.7.1 Rest of LAMEA eClinical Solutions Market by Delivery Mode
8.7.2 Rest of LAMEA eClinical Solutions Market by Product
8.7.3 Rest of LAMEA eClinical Solutions Market by Clinical Trials Phase
8.7.4 Rest of LAMEA eClinical Solutions Market by End User
Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Anju Software, Inc.
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Acquisition and Mergers:
9.3 eClinical Solutions LLC
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Acquisition and Mergers:
9.4 Castor EDC
9.4.1 Company Overview
9.4.2 Recent strategies and developments:
9.4.2.1 Partnerships, Collaborations, and Agreements:
9.5 Signant Health
9.5.1 Company Overview
9.5.2 Recent strategies and developments:
9.5.2.1 Product Launches and Product Expansions:
9.6 Dassault Systemes SE
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.7 Parexel International Corporation (Phoenix Parentco, Inc.)
9.7.1 Company Overview
9.8 Clario
9.8.1 Company Overview
9.9 BSI Life Sciences (Business Systems Integration AG)
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Partnerships, Collaborations, and Agreements:
9.10. MedNet Solutions
9.10.1 Company Overview

Companies Mentioned

  • Oracle Corporation
  • Anju Software, Inc.
  • eClinical Solutions LLC
  • Castor EDC
  • Signant Health
  • Dassault Systemes SE
  • Parexel International Corporation (Phoenix Parentco, Inc.)
  • Clario
  • BSI Life Sciences (Business Systems Integration AG)
  • MedNet Solutions

Methodology

Loading
LOADING...